Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase
about
Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeys[Fast-acting insulin - new developments towards more flexibility for the patient].Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.Ultrafast-acting insulins: state of the artOverview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies.Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders.Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.Insulin analogues in type 1 diabetes mellitus: getting better all the time.A novel option for prandial insulin therapy: inhaled insulin.Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy Subjects.Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.Therapy of Type 1 Diabetes Mellitus
P2860
Q28535043-EEBA34C6-519F-4560-BB98-F58FDC398EEAQ30313628-46B6CE10-57DA-4209-AC4A-DABDBC9F8933Q36158995-83E6401E-A250-4CA7-947F-0F5E2A28121AQ37320243-F9DFA24B-40A7-4FC6-B284-7B01A6245496Q38037727-5E1716EE-D8CB-4AED-A098-57590B5D662BQ38217591-87ABA20B-EC83-485A-B6F5-6828B76E9981Q38219946-1CEF20B1-7D78-4E08-B42C-14118E8A79F5Q38652925-84614EC7-795D-4ACA-8267-7BF9AD16F72BQ38692387-F81E139B-391E-4DED-896C-2AFFD33D650AQ38942445-49732E72-5A99-470F-852C-D7F0D47B3804Q43094790-ADE40BD5-89C7-42EE-B675-97A76A12AB37Q50016364-B18F41BD-D8F8-4D86-93D1-A48344D5004AQ50034109-968AC391-206C-407B-BFE7-F8045ED258A4Q57412611-DAC95D02-A002-49A0-BD0B-7E43615C67C0
P2860
Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Accelerating and improving the ...... ecombinant human hyaluronidase
@ast
Accelerating and improving the ...... ecombinant human hyaluronidase
@en
type
label
Accelerating and improving the ...... ecombinant human hyaluronidase
@ast
Accelerating and improving the ...... ecombinant human hyaluronidase
@en
prefLabel
Accelerating and improving the ...... ecombinant human hyaluronidase
@ast
Accelerating and improving the ...... ecombinant human hyaluronidase
@en
P2860
P1476
Accelerating and improving the ...... ecombinant human hyaluronidase
@en
P2093
Daniel E Vaughn
Douglas B Muchmore
P2860
P304
P356
10.1177/193229681200600405
P577
2012-07-01T00:00:00Z